Syncom Formulations (India) Ltd Performance
Day's Low
Day's High
₹19.6₹20.2852 Week's Low
52 Week's High
₹9.8₹27.9
| Returns % | |
| 1 Month Return | + 1.2 % |
| 3 Month Return | + 5.82 % |
| 1 Year Return | + 102.81 % |
| Market Stats | |
| Previous Close | ₹20.18 |
| Open | ₹20.10 |
| Volume | 29.15L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,896.92Cr |
Syncom Formulations (India) Ltd Key Statistics
| P/E Ratio | 43.87 |
| PEG Ratio | 292.46 |
| Market Cap | ₹1,896.92 Cr |
| P/B Ratio | 3.67 |
| EPS | 0.27 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 8.71 |
Syncom Formulations (India) Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,896.92 Cr | 573.53% | 0.61 | ₹25 Cr | ₹263 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Syncom Formulations (India) Ltd Mutual Fund Holdings
About Syncom Formulations (India) Ltd
Share Price: ₹19.77 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹1,896.92Cr as of today
Revenue: ₹102.31Cr as on September 2024 (Q3 24)
Net Profit: ₹11.11Cr as on September 2024 (Q3 24)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
| Organisation | Syncom Formulations (India) Ltd |
| Headquarters | Indore |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Syncom Formulations (India) Ltd
Syncom Formula Reports Strong Q2 Growth - 13 Nov, 2024
Syncom Formula's standalone net sales for September 2024 reached Rs 101.49 crore, up 62.68% YoY. Net profit increased by 76.46% to Rs 10.95 crore, with EBITDA rising 59.5%. The EPS doubled to Rs 0.16. The stock has shown impressive returns of 62.45% over six months and 106.83% over twelve months.
Insights on Syncom Formulations (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 6 quarters, 4.4 Cr → 11.11 Cr (in ₹), with an average increase of 15.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, SYNCOMF stock has moved up by 51.2%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 6 quarters, 61.71 Cr → 106.46 Cr (in ₹), with an average increase of 10.2% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SYNCOMF has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.09% to 0.10% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 17.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.57% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 49.34% to 49.33% in Sep 2024 quarter
Syncom Formulations (India) Ltd Financials
Index Inclusions
Syncom Formulations (India) Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.57% | 0.00 | |
| Foreign Institutions | 0.1% | 16.05 | |
| Mutual Funds | 0% | 100.00 | |
| Retail Investors | 49.33% | ||
| Others | 0% | 0.00 |
Syncom Formulations (India) Ltd Key Indicators
Syncom Formulations (India) Ltd Valuation
Syncom Formulations (India) Ltd in the last 5 years
Lowest (3.98x)
March 12, 2020
Today (43.87x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (81.74x)
January 18, 2022
Syncom Formulations (India) Ltd Earnings and Dividends
Syncom Formulations (India) Ltd Earnings Results
Syncom Formulations (India) Ltd’s net profit jumped 70.66% since last year same period to ₹11.11Cr in the Q2 2024-2025. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 45.61% jump in its net profits since last 3-months.
Read More about Earnings ResultsSyncom Formulations (India) Ltd Dividends August,2022
In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.15%.
Read More about Dividends
Syncom Formulations (India) Ltd Technicals Summary
Bearish
Neutral
Bullish
Syncom Formulations (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Syncom Formulations (India) Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Syncom Formulations (India) Ltd shares.
Syncom Formulations (India) Ltd (SYNCOMF) share price today is ₹19.77
Syncom Formulations (India) Ltd is listed on NSE
Syncom Formulations (India) Ltd is listed on BSE
- Today’s highest price of Syncom Formulations (India) Ltd is ₹20.28.
- Today’s lowest price of Syncom Formulations (India) Ltd is ₹19.6.
PE Ratio of Syncom Formulations (India) Ltd is 43.87
PE ratio = Syncom Formulations (India) Ltd Market price per share / Syncom Formulations (India) Ltd Earnings per share
Today’s traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 29.15L.
Today’s market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1896.92Cr.
| Syncom Formulations (India) Ltd(SYNCOMF | Price |
|---|---|
52 Week High | ₹27.9 |
52 Week Low | ₹9.8 |
Syncom Formulations (India) Ltd(SYNCOMF) share price is ₹19.77. It is down -29.14% from its 52 Week High price of ₹27.9
Syncom Formulations (India) Ltd(SYNCOMF) share price is ₹19.77. It is up 101.73% from its 52 Week Low price of ₹9.8
| Syncom Formulations (India) Ltd(SYNCOMF | Returns |
|---|---|
1 Day Returns | -0.41% |
1 Month Returns | 1.2% |
3 Month Returns | 5.82% |
1 Year Returns | 102.81% |